Skip to content

Clinical trials

Alzheimer Disease trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Finland Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20062
20072
20083
20097
20102
20112
20121
20133
20145
20156
20163
20174
20185
20193
20201
20214
20224
20233
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated25
Recruiting4
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
GlaxoSmithKline5
H. Lundbeck A/S5
Novartis Pharmaceuticals5
Pfizer5
Biogen3
Bristol-Myers Squibb3
Eli Lilly and Company3
Kuopio University Hospital3
University of Eastern Finland3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease66
Dementia20
Cognitive Dysfunction12
Brain Diseases8
Neurodegenerative Diseases7
Nervous System Diseases6
Central Nervous System Diseases5
Memory Disorders5
Frontotemporal Dementia4
Mental Disorders4

Trials

Showing 76 to 66 of 66. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.